Thompson Siegel & Walmsley LLC Assertio Holdings, Inc. Transaction History

Thompson Siegel & Walmsley LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$2.52 - $5.69 $2.56 Million - $5.79 Million	1,017,436 Added 489.63%	1,225,233 $3.14 Million
Q2 2023 Aug 10, 2023	SELL	$5.0 - $7.66 $79,505 - $121,801	-15,901 Reduced 7.11%	207,797 $1.13 Million
Q1 2023 May 11, 2023	SELL	$3.54 - $6.66 $197,609 - $371,774	-55,822 Reduced 19.97%	223,698 $1.43 Million
Q4 2022 Feb 10, 2023	BUY	$2.11 - $4.3 $589,787 - $1.2 Million	279,520 New	279,520 $1.2 Million
Q3 2022 Oct 25, 2022	BUY	$2.13 - $4.0 $46,191 - $86,744	21,686 Added 12.8%	191,159 $434,000
Q2 2022 Jul 22, 2022	BUY	$1.88 - $3.42 $11,898 - $21,645	6,329 Added 3.88%	169,473 $500,000
Q1 2022 Apr 26, 2022	BUY	$2.06 - $3.0 $336,076 - $489,432	163,144 New	163,144 $468,000

114

37.2M

755K

39.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $58.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.